News Snapshot:
Warburg-Backed Hong Kong Firm That Uses AI for Drug Discovery Files for U.S. IPO (Bloomberg) -- Insilico Medicine, a Hong Kong-based company that uses artificial intelligence to drive drug discovery, filed confidentially for a U.S. initial public offering last week, according to people familiar with the matter. Most Read from Bloomberg - [Supply Chain Crisis Risks Taking the Global Economy Down With It] - [China’s Climate Goals Hinge on a $440 Billion Nuclear Buildout] - [Atlanta’s Crowded Election Pits Former Mayor Versus ‘Anyone But’] - [Results on Key Ballot Initiatives, From Policing to the Environment] - [Into the Metaverse: Where...
